Tough reelection? Sponsor an opioid bill

https://static.politico.com/dims4/default/9bfde67/2147483647/resize/1160x/quality/90/?url=https%3A%2F%2Fstatic.politico.com%2Fd4%2Fe1%2Fff426c2c4d1bbc957a99dfbbc6df%2F180615-greg-walden-gty-1160.jpg

Tough reelection? Sponsor an opioid bill

Most of the bills sponsored by vulnerable lawmakers are not controversial, in part because they don’t designate new spending

https://www.politico.com/story/2018/06/16/lawmakers-opioid-bills-midterms-624926

Everybody wants their name on a bill addressing the opioid crisis — especially Republicans facing tough reelection battles.

That’s why House leadership will bring more than 70 such bills to the floor by the end of the month, many sponsored by the most vulnerable members of the GOP conference. The schedule allows lawmakers to show they’re trying to combat a public health emergency that claims 115 lives per day and is a top concern of midterm voters. But it’s a cumbersome, piecemeal approach involving hours of votes on narrow bills that Democrats complain don’t go far enough and are being rushed through the legislative mill.

“We know we’ll have to pull them together at some point, but they put a lot of work into them,” said House Energy and Commerce Chairman Greg Walden (R-Ore.), whose panel originated most of the measures. “Everybody has their own idea and their own cause and thing they’re working on.”

This week alone, the House passed more than 30 bills sponsored by members from both parties, mostly by voice vote with no dissent. Democrats aren’t shy about touting their involvement, despite their misgivings about the overall process: Energy and Commerce ranking member Frank Pallone (D-N.J.) took credit for one bill that would expand the FDA’s power to stop illegally made opioids from arriving through international mails.

But it’s House Republicans who most feel the need to promote their legislative accomplishments. Eleven of the 17 GOP incumbents the nonpartisan Cook Political Report classifies as in toss-up races are primary sponsors of legislation that is expected to be considered by the House this week or next.

For good reason. The drug abuse epidemic is sure to again be a top issue with voters heading into the midterms. A CBS News poll from May found 71 percent of voters described it as a “very serious” issue facing the country, including 78 percent of Republicans, 72 percent of Democrats and 67 percent of independents. Nearly 80 percent of all voters said the federal government should do more to address the crisis.

Bringing dozens of bills to the floor, instead of one comprehensive measure, makes it easier for members to show they’re engaged, said former Republican Rep. Mary Bono, who now advocates for people recovering from addiction and is co-founder of the Collaborative for Effective Prescription Opioid Policies. “It’s hard to go out on the campaign and say I negotiated this provision into the bill,” she said. “Leadership recognizes they should give credit where credit is due.”

Responding to the crisis was a pillar of President Donald Trump’s campaign that helped capture hard-hit states like West Virginia, where he received nearly 70 percent of the vote. But critics say all the talk hasn’t translated into meaningful results, and they blame Republicans for simultaneously undercutting critical safety net programs like Medicaid.

“Republicans aren’t addressing the problem in a meaningful way,” said Rep. Jared Polis (D-Colo.), who is running for governor in his state. “If Republicans were serious about dealing with opioids, they would drop their assault on Medicaid,” he said, adding that the GOP’s efforts to repeal Obamacare would be disastrous for people with substance abuse issues.

The American Action Network, a GOP outside group, has launched a six-figure ad buy in 28 districts with competitive races, touting Republican candidates’ efforts to work across party lines to address the crisis.

“Members of Congress need to go in front of their constituents and explain to them what they’ve done to make their community a better place,” said Corry Bliss, executive director of the American Action Network and Congressional Leadership Fund.

Rep. Buddy Carter (R-Ga.) said voting on narrow bills one-by-one can prevent the legislation from getting bogged down by political roadblocks.

“There are a lot of good ideas out there,” he said. “And sometimes when you put them all together, then it kind of causes problems.”

Republican supporters of the bills say the extended time on the floor reflects how seriously the House takes the opioid issue.

Most of the bills sponsored by vulnerable lawmakers are not controversial, in part because they don’t designate new spending. Rep. Barbara Comstock of Virginia, who polls show trailing a Democratic challenger in her suburban swing district outside Washington, D.C., sponsored one measure that passed and would require HHS to issue guidance on obtaining better clinical data on non-opioid alternatives.

Likewise, Rep. Carlos Curbelo of Florida, who polls also show is trailing in one of the most competitive races in the country, has a bill that would require HHS to develop a toolkit for hospitals to help reduce opioid misuse.

Other bills focus on propping up the behavioral health workforce, expanding access to treatment and curbing the flow of illicit substances.

The House-approved bills are expected to be combined into a single package that will be sent to the Senate. There, lawmakers plan to bring their own anti-opioid legislation to the floor next month. The HELP and Finance committees have combined their opioid-related bills into one legislative package each. It’s unclear whether amendments will be allowed on the Senate floor — a process lawmakers would like, but that could up take time.

Advocates are divided on how much the work will reduce overdose deaths and prevent more people from becoming addicted.

“It’s a very comprehensive response,” said Jessica Nickel, founder and CEO of the Addiction Policy Forum. “It addresses non-opioid alternatives, important prevention programs and child welfare components. It’s a really important step.”

But some say that without guaranteed, long-term funding, the legislation won’t make much of a difference.

“This is not going to fix the problem,” said Mark Covall, president and CEO of the National Association for Behavioral Healthcare. “We need to find a sustainable solution. We shouldn’t be looking at it from a grant-based system.

This has been a long-term problem that is not going to go away.“

Pick whatever you want 2 -3 -12 million .. as the number of serious addicts/substance abusers..  No matter which number you chose … it is dwarfed by the number  of chronic pain pts..  but who does the 435 member of House of Representatives  claims to care about ?

According to this article, they are still using the “fake facts”  from the CDC of 115 lives OD’s every day. Who recently admitted that they overstated that number by 53%.

If you are a chronic pain pt .. you probably need to research your Federal Representative position on this issue – opiate abuse – which they admit  –

This has been a long-term problem that is not going to go away.

Congress Demands Justice Department Return Millions “Seized Unfairly” From Taxpayers- beginning of the end for civil asset forfeiture ?

https://www.forbes.com/sites/nicksibilla/2018/07/20/congress-demands-justice-department-return-millions-seized-unfairly-from-taxpayers/#2fa782421043

In the latest salvo against civil forfeiture, 21 Republican Members of Congress sent a letter to Attorney General Jeff Sessions on Thursday that demanded the Justice Department “immediately return” up to $22 million that was “seized unfairly by the government.” Using civil forfeiture, the Internal Revenue Service raided bank accounts from hundreds of owners for alleged “structuring” offenses, which involves making a series of cash transactions under $10,000 to skirt federal reporting requirements.

“What was done was not fair, just or right in most cases,” the letter declared, which was co-signed by House Ways and Means Chair Kevin Brady (R-TX), Oversight Subcommittee Chair Lynn Jenkins (R-KS), and former Oversight Subcommittee Chair Peter Roskam (R-IL). “The IRS’s actions led to the destruction of many lives and small businesses, some of which will never fully recover.”

In response to a public backlash, the IRS announced two years ago that it would notify owners who had their property forfeited under structuring laws that they could file petitions to recover what was taken. Appearing before a House Ways and Means Oversight Subcommittee hearing last month, representatives from both the IRS and Justice Department provided an update on the structuring petitions they had received. The contrast between the two agencies was stark.

After mailing over 1,800 letters to property owners, the IRS received 464 petitions. Upon further review, only 208 petitions were within its jurisdiction. Among those petitions, the IRS decided to grant 174 (or roughly 84 percent), and returned over $9.9 million to property owners.

For the remaining 256 petitions, the IRS sent those to the U.S. Department of Justice, and recommended that DOJ grant 194 of those petitions. Yet the Department only accepted 41 petitions—less than 1 in 6 petitions—and refused to return more than $22.2 million.

Slamming DOJ’s position as “wholly indefensible,” the Members of Congress wrote that they were “profoundly troubled by the significant discrepancy between the IRS’s recommended outcome and DOJ’s final decisions.” “By DOJ’s own testimony, the mitigation process acts as a pardon request, permitting a plea for leniency,” noted the letter. “It provides DOJ with a safety valve that allows for the correction of actions taken by the Government, which in hindsight, we may realize were in error. This is one of those instances.”

Although structuring was promoted as a way to combat money laundering, drug trafficking, and other criminal enterprises, the IRS regularly seized money that had been legally earned by small business owners. In fact, a report by the Treasury Inspector General for Tax Administration found that out of a sampled 278 structuring cases, 91 percent were “legal source cases,” i.e. they were not derived from illegal activity.

But in October 2014, the IRS announced that it would no longer confiscate cash from legal source structuring cases, after The New York Times ran a front-page story on new lawsuits filed by the Institute for Justice that challenged structuring. As for illegal source cases, the IRS has only conducted 32 seizures since the new policy was implemented.

The shift in policy was an important win for private property rights and due process. But it did not apply to owners who had their cash confiscated before the policy change. In order to help prior victims of structuring get back their money, the Institute for Justice filed “petitions for remission or mitigation” in 2015, paving the way for others to follow. In less than a year, IJ successfully secured the return of $29,500 taken from Randy Sowers, a Maryland dairy farmer, and more than $150,000 that was forfeited from Ken Quran, who runs a convenience store in rural North Carolina. Neither man was ever charged with a crime.

Now the fate of the 194 owners denied their property’s return by DOJ may ultimately lie with Jeff Sessions, one of the nation’s top cheerleaders for civil forfeiture. Last summer, the Attorney General reversed restrictions placed on “adoptive” forfeitures, making it easier for local and state agencies to circumvent state laws that protect innocent owners. He later defended that decision by declaring, “I love that program. We had so much fun doing that, taking drug dealers’ money and passing it out to people trying to put drug dealers in jail. What’s wrong with that?”

Yet even Sessions has voiced qualms about structuring. During a 2015 Senate Judiciary Committee hearing on civil forfeiture, then Sen. Sessions said he believed that that “structuring can be abused,” and “people have made some valid points about it.”

” 100 yr dash” for a chain pharmacy technician ?

How do i get faster? I’m told I’m too slow. 80 seconds to grab medication. Count it. And label the bottle and place in the rack is too slow. 150 seconds to greet the customer. Get their medication. Take care of any issues and bag their stuff is too slow. I need to cut that time in half according to my boss.

60 seconds max per customer and 30-40 seconds to dispense. And maybe 30 seconds or less on data entry.

I’ve only improved by a couple seconds in 90 days.

What happened to ensuring patient safety these chains market to their customers?

 

 

How to find a local independent pharmacy/Pharmacist

Drug Firms Blame Opioid Crisis on Illicit Websites, Dealers -filing lawsuits

Drug Firms Blame Opioid Crisis on Illicit Websites, Dealers

https://www.bloomberg.com/news/articles/2018-07-19/drug-companies-seek-to-blame-opioid-crisis-on-illegal-dealers

Two pharmaceutical companies say the real culprits in the opioids epidemic are illegal dealers of the painkillers and want them to be on the hook financially for any damages potentially assessed against drugmakers.

Endo International Plc and Mallinckrodt Plc sued a host of convicted drug dealers and Internet sites this week for illegally offering opioids. Among them: RxCash.Biz, which offers misbranded opioids online, an Italian man indicted for of operating so-called pill mills, and a Tennessee resident who’s serving 10 years for possessing fentanyl with an intent to distribute.

The companies also named Tennessee counties and towns, seeking a ruling that effectively limits the firms’ financial responsibility over claims they fueled a public-health crisis through their marketing of the prescription painkillers.

The suit, filed July 16 in state court in Kingsport, Tennessee, comes almost two months after a Tennessee judge rejected Endo’s and Mallinckrodt’s push to have the Tennessee municipalities’ opioid suit thrown out. Tennessee Attorney General Herbert Slatery III also sued opioid makers in May, saying their marketing of the drugs as nonaddictive violated federal and state laws.

If lawyers for Tennessee cities and counties persuade a jury to tag Endo and Mallinckrodt with millions in damages over their opioid sales, the drugmakers argue, they “are entitled to contribution from the illegal supply chain defendants,’’ according to court filings.

Gerard Stranch IV, a lawyer for Sullivan County, Tennessee, which is among the municipalities that sued the companies, said the case is frivolous.

“They’re basically suing us for not having enough body bags on hand to clean up after their mess,” he said. “It’s a PR stunt. What they’re trying to do is intimidate other cities and counties from filing these lawsuits against them.”

Opioid Judge Wants ‘Meaningful’ National Accord on Cities Suits

Endo and drugmakers Johnson & Johnson and Purdue Pharma LP are among the companies in talks with state attorneys general and lawyers representing cities and counties seeking a resolution of cases accusing the companies in the crisis. A judge in Cleveland overseeing the consolidation of local governments’ opioid suits has said he wants a deal that goes beyond money, addressing the companies’ business practices and the roots of the crisis that claims the lives of more than 100 Americans daily.

Endo, which makes the drug Opana, and Mallinckrodt, which produces a generic version of Oxycodone, say that 90 percent of opioid overdoses “involve illegal, non-prescription opioids and the majority of those who misuse prescription medications obtain their pills illegally.’’

Pharma companies have no duty to deter “illegal pill mills and unscrupulous doctors who divert legal drugs for illegal purposes,’’ their lawyers noted.

“This is the first in the nation type of filing that properly describes the cause of the so-called opioid epidemic as the true source, which is the illegal supply chain, which has been documented by regulators, the scientific community and even some of the authorities connected with the plaintiffs themselves,” said John Hueston, an outside attorney for Endo.

Stranch said the companies’ complaint cites a database the cities and counties don’t have access to, and pointed out that the drugmakers didn’t use that information to help stem the epidemic. He said that the companies are challenging findings that the court already made and trying to re-litigate the case.

He said he asked for information about any diversion of opioids to potential pill mills, as well as the identities of doctors suspected in overprescription or diversion activities and the drugmakers have refused to provide them.

Opioids and Heroin and the U.S. Epidemic of Addiction: QuickTake

Barry Staubus, Sullivan County’s district attorney, said the suit is without merit. Under Tennessee law, prosecutors can bring such civil cases on behalf of the residents of their counties.

“We’ve been inundated by opioids and we’ve done the best we can,” he said. “They’re trying to shift responsibility from themselves to someone else.”

Other plaintiffs include two other district attorneys and a baby, who allegedly was born with neonatal syndrome because of exposure to opioids. The two lawyers couldn’t be reached for comment.

“The whole idea is ridiculous,’’ said Paul Hanly, a New York-based plaintiffs’ lawyer and one of the leaders of the Cleveland process. “I don’t see why the drug companies think they should be absolved from liability for the conduct of third parties. I don’t think it will fly.’’

In its filing, Endo and Mallinckrodt seek a ruling barring the municipalities from challenging in the future a jury’s division of damages between the companies and the drug dealers.

The case is Endo Health Solutions Inc v. Alfa Bay, No. C-41916, Div-C, Sullivan County Circuit Court (Kingsport, Tennessee)

KARMA – can be a BITCH !

I did this post a few days ago

My Pharmacist Humiliated Me When He Refused to Fill My Hormone Prescription and ACLU cares about this denial

Below are a few posts from a Face Book page…. apparently from some techs that worked with this particular pharmacist and the issue was from back in April  but chain pharmacies do not like BAD PRESS… it would appear that CVS had put up with this pharmacist’s attitude for some time without taking any action.

“So I worked with the pharmacist in question in this article and I can say that he denied a lot of scripts for no logical reasoning…. he truly is a horrible human being.”

  “this pharmacist is the most egotistical jackass I have ever worked with. He absolutely refused to do anything besides verification because everything else is considered “tech work” he also spoke to the staff in a condensening manner and said things such as “I am a pharmacist, you are a tech, you do not speak unless spoken to”

1) this was from april…. 2) the pharmacist in question has been terminated (rightfully so)… 3) customer relations is as helpful as our cvs help desk (helpless desk) … 4) good for her speaking her mind and bringing this to light

In the trenches: Behind the counter with 3 pharmacists

I normally don’t put IMO at the front of posts but … I wanted to increase the probability of this one being read… this article compares three very different Rx dept and how they function…  Both of the chain pharmacists mention substance abuse in one form or another and technician staffing issues and or justification to come in early – off the clock – to get things together for the day. The independent pharmacy/owner apparently doesn’t worry about either because she determines staffing levels and most likely knows her pts and has a “working relationship” with the local doctors.  While these stories are suppose to be anonymous.. From what is said, I am pretty sure that one is a BIG BOX STORE and the other one is one of the two largest chain stores. The points out the “interference” that the Pharmacist has to put up with from the non-pharmacist store manager and how data driven and time sensitive  the whole process is. Legally, the non-pharmacist store manager has NO AUTHORITY in the Rx dept, but healthcare – especially the chains – in nothing more than a FOR PROFIT BUSINESS… Get them into the store… get their money… and get them out… and if the Pharmacist complains or files a complaint.. she will find herself “sitting on the curb” and we have a serious and growing surplus of Pharmacists… so the majority of chain pharmacists just shut up and go along… This article just reinforces my normal suggestion to use a independent pharmacy …  here is a link to find one by zip code  http://www.ncpanet.org/home/find-your-local-pharmacy 


https://www.drugstorenews.com/insights/in-this-issue/in-the-trenches-behind-the-counter-with-3-pharmacists/

What keeps a pharmacist up at night? Sounds a bit cliché, doesn’t it? But retail pharmacists are confronted with many different issues throughout their day, from dealing with patients to company and government regulations that can make the job a bit tougher.

Although retail pharmacists across the United States work in many different settings, many face similar challenges. Drug Store News talked to three pharmacists — without identifying them or their employers — to capture a day in their work life and explore challenges they experience, as well as solutions.

Here is what we learned:

Case 1: Independent pharmacist near Seattle
At this bustling independent pharmacy, the pharmacists all focus on non-sterile compounding for the local community. The pharmacist said that many competitors focus on marketing and compounding for out-of-area patients, as well as local consumers, but employees at this operation focus on building relationships with local doctors and serving the community.

The independent employs a distinct, high-tech process for filling prescriptions. A technician performs data entry, including resolving insurance rejections, and then a second technician processes the prescription out of the packaging queue. No paper or labels are printed until the script is ready to be filled, reducing unnecessary use of paper. The second technician is located at a station that has a tech solution called Eyecon, which uses infrared technology to store pill images and ensures accuracy on filling, as well as RxSafe.

RxSafe is a tower containing a large portion of the inventory that can store up to 1,200 stock bottles. Once the label is printed, the technician scans the label, and the RxSafe sends out the stock bottle of medication. Eyecon scans the label and stock bottle for accuracy. It will alert the technician of an error by flashing red, even if the correct drug is scanned, and there is a distraction, and the wrong drug gets poured onto the counting tray.

At this operation, the pharmacist employs the use of a hanging bag system. By the time the prescription reaches the pharmacist for verification, it already is in the bag. This has saved a lot of time in the bagging process and allowed them to eliminate baskets. She has had success purchasing these bags at a better price by searching online for hanging library bags, which can be found at a larger variety and at better pricing. The pharmacist said the system “keeps things looking neat,” and that it is a “seamless process that eliminates a few extra steps.”

What is her favorite aspect of independent pharmacy? “The connection with customers and prescribers,” she said. Once the pharmacy began compounding, doctors started to view it in a more clinical light and started asking a lot of clinical questions they never asked when the pharmacy did not compound. Now, she said, they are viewed “as colleagues, someone who can help solve medical problems.” She enjoys the family environment of her independent pharmacy and being her own boss. She also enjoys the benefits of being a member of Professional Compounding Centers of America, which has a network of 30 pharmacists she can call for help if she needs assistance finding an answer to a tough question.

The pharmacist noted that it is important for independent owners to be alert to the possibility of employee theft. She told of a technician, who worked at the store and was later discovered to have been stealing from the company in a number of ways. This technician processed prescription refunds onto her own credit cards and opened fake charge accounts. At one point, the credit card company was alerted because thousands of dollars were being refunded onto her credit card.

The company, recognizing that this often is caused by employee theft, contacted the pharmacist and the employee’s stealing was uncovered. She noted that this employee was an otherwise star worker, often proudly pointing out ways that she had helped make money for the pharmacy. The technician worked hard to be her right-hand woman, she said.

The pharmacist said that a red flag with this technician was always printing unnecessary financial reports for her job description. She explained that by doing so, dishonest employees can gain access to information they use when developing their strategy.

The independent pharmacist stressed that since internal theft can be very damaging, owners must take extra steps to protect their assets. Employees should not have charge accounts nor should be able to create or edit charge accounts for others — only a very limited number of trusted employees should be able to do so, she said.

She also recommended that registers should be password protected. Only the pharmacist should be able to authorize a discount, price change or refund. She noted that proper security on the register is just as important as learning how to operate it.

A nice niche that she has carved out for the independent operation is bringing in high-end vitamin lines that cannot be found in chains. She started with Thorne vitamins and expanded to several others, with the store now carrying multiple lines of vitamins that typically do not sell to chains. She described it as an “additional revenue source and clinical service,” that the pharmacists enjoy and that helps the pharmacy stand out.

As is the concern with most independent pharmacies, she noted that insurance reimbursements have gone down, but she is “hopeful that PBM reform will come and is somewhat encouraged for the future.” The pharmacist advised fellow pharmacists to get involved with or donate to state and national pharmacist associations to help them promote and fight for the profession.

Case 2: Pharmacist working for a national retail operation for the last 15 years, and is now working in a high-volume store located in the Philadelphia area

At this chain, pharmacists work 10-hour shifts. The pharmacist said she arrives 30 minutes early — by choice and on her own time — to “get in and get settled.”

When she arrives, she knows that her resolution queue awaits and will only grow longer if she doesn’t work on it, undisturbed, before opening time. The resolution queue includes all prescriptions that must be addressed, such as prior authorizations, doctor calls and any troubleshooting issues. She explained that there could be 80-plus items in the queue when she arrives, and there is not a specified time when the prescriptions are due.

Generally, though, the system ranks prescriptions by priority — those due in the next 30 minutes, two hours or 72 hours. If a pharmacist starts to fall behind, the items will turn yellow to signal a deadline getting closer, or red if they are past due. Technicians and pharmacists must be efficient in watching priority and keeping prescriptions in order, she said.

At this operation, technicians are expected to fully answer phones and perform all data entry. She explained that they try to “create an environment leaving the least distractions for the pharmacist because no one else can do what I do.” A policy called “three before me” encourages technicians to collaborate and problem solve by asking three other people — if available — before asking the pharmacist. Usually, another technician can help solve the problem, allowing the pharmacist to concentrate on verification and clinical matters.

Prescriptions are checked in two stages. After the technician performs data entry, the pharmacist does a four-point check, verifying the accuracy of the data entry — patient name, drug/strength, directions, doctor. Any mistakes must be sent back to the technician to correct — pharmacists are not allowed to fix mistakes.

Once the prescription passes the four-point check, it can then go to the fill queue by time priority. After the technician prepares the prescription, the pharmacist visually verifies the prescription by looking at the pill image and comparing it with the pills in the bottle. The technician then bags the prescription.

Prescription input is always a priority over the dozens of prescriptions that are due in 72 hours. “We don’t have the payroll to work three days ahead,” she said, noting that the filling process is all about “minimizing distractions for the pharmacist.”

Pharmacists are required to counsel patients on all new prescriptions at this chain. The pharmacist explained that often, patients will decline counseling, saying they have taken that medication before. However, she encourages them to step over and speak to her for a brief moment, when she can check the patient profile on her computer. Sometimes, a dosage change by the doctor that was unintentional is discovered, and this extra step provides an important opportunity for this pharmacist and her colleagues to evaluate the drug(s) and clear up any questions.

At this retailer, there is a drive for immunizations, and pharmacists are expected to consult with patients about available and appropriate options being offered. Like many other pharmacy retail chains, there are quotas that pharmacists attempt to meet with regards to immunizations. There also is a very big focus on medication therapy management, with pharmacists required to sign on daily to ensure patients are adherent and the company is compliant with insurance requirements.

This pharmacist’s favorite part of the job: “The biggest joy is making a difference for a patient,” she said, explaining that the world is motivated by time and money. Since the chain offers low prices, it makes a huge impact on a patient when she is able to help them save $200 to $300 per month, and they are extremely grateful.

Her least favorite part of the job: “Without a doubt, the opioid epidemic.” She checks the prescription-monitoring program for controlled substances. At the chain, pharmacists must establish a doctor-patient relationship and ensure that it is an appropriate relationship, gathering such information as diagnosis and date of last visit. She said it sometimes is difficult to have these conversations with the doctor and the patient, but they are necessary in using figuring out whether a prescription is appropriate.

The pharmacist “takes every prescription on a case-by-case basis,” looking at the history, consulting the doctor if necessary and checking the PMP. For example, she would not call a doctor for a child on a low dose of Adderall, but if a patient is on a very high dose of oxycodone, she would make the call. With the opioid epidemic at an all-time high, she said pharmacists need to take the time and responsibility to take every step necessary.

Many times, she will refuse to fill a prescription of high-dose narcotics, and she feels confident that her company supports her professional judgment.

What would she change, if given the opportunity? “We are pulled in too many different ways, and everyone expects everything in 10 minutes or less.” Also, she would increase technician help and/or lower expectations — she finds it nearly impossible to perform all the daily tasks. She explained that if a pharmacist is filling 300 prescriptions in 10 hours, plus immunizations, counseling, MTM and checking PMP, it can be difficult to stay afloat.

Case 3: A pharmacist-in-charge at a low-volume national chain store in South Carolina
An interesting concept that this chain employs is called workload balance. Pharmacists use a tool that allows them to check data entry, but if they are caught up on their work, they will check data entry of other stores in the chain across the country. Like other major pharmacy retailers, this operation has a two-part checking system — first, the data entry is reviewed and then the pill image is verified.

Because of the lower volume at the store, the pharmacist has a budget of just 70 technician hours — down from 140 just 18 months ago. Because the technician is busy with data entry, register and drive-through, the pharmacist must do all production by herself because, when there is only one technician working with her, they are both “at capacity.” Additionally, due to the lack of enough help, the pharmacist often finds it difficult to find time to do other tasks, such as making the schedule and completing adherence calls. “We’re all stretched thin, that’s just how it is,” she said.

The pharmacist remembered a time when she took a 20-minute meal break, and there were only 10 prescriptions pending. When she came back, a customer was yelling at her technician and 45 prescriptions were in the queue. It took her three hours to catch up.

On top of all of the catching up she had to do, the store assistant manager came to the pharmacy to tell her to check her tasks, which were showing as incomplete in the company’s computer system. She explained that it is challenging that store managers are not pharmacists, but that the pharmacist reports directly to the store manager. “They just don’t get it,” she said. “Our direct report has absolutely no idea what it’s like to be a pharmacist.”

She also told of a time when a patient became very ill due to a drug interaction that was not picked up by the computer. Although this would have happened to any pharmacist, the store manager wanted to fire the pharmacist. She had to explain that the system failed, not the pharmacist. She would like to see better cross-training of store managers and have them spend more time in the pharmacy, learning how to complete pharmacy tasks and understand a little more about what the pharmacy staff does.

So, what is the favorite part of her job? “I really like helping people.” She gives patients her full attention when giving recommendations. “I always walk the patient to the shelf,” she said, explaining to the patient why she is selecting that particular product. She enjoys teaching the patients and giving them ownership. Although it is her favorite part of the job, she doesn’t get to do it as much as she likes.

One challenge at this pharmacy is dealing with the over-the-counter sale of syringes. State law and company policy require pharmacists to sell syringes to any patient without a prescription. On one hand, she knows that providing easy access to syringes is helpful to prevent such diseases as HIV and hepatitis for patients who have substance use disorders and use syringes to inject.

On the other hand, customers who buy these syringes are using them in the bathroom, leaving needles sticking out of the garbage cans. Store employees also have found needles in the parking lot and on shelves throughout the store. This presents a danger to employees and other customers. Despite talking to management and the human resources department about these issues, they persist. “They give us thick gloves,” she said. The pharmacist hopes that by continuing dialogue and problem-solving, sharps containers will be required to be sold with syringes, and/or sharps containers will be placed in the store bathrooms.

#CBS News Appalling Coverage

This video is not only about the appalling coverage by CBS News but all major news outlets. I could just as easily of named Fox News, the Washington Post or even Andrea McCarren of WUSA Channel 9, Washington DC (another CBS affiliate) who has now blocked me on Tweeter for requesting her assistance in exposing these genocidal policies. Sadly they all REFUSE to contact me even after hundreds of emails, Tweets & even phone calls. America needs to know the truth. President Trump needs to know before he can help. Who among you are willing to spread the horror stories from coast to coast? Remember; just one second! One accident. One diagnosis. In just one second any of you can join us as the 100 million forgotten Americans left to suffer cruel and inhumane torture daily. Robert D. Rose Jr. BSW, MEd. USMC Semper Fidelis

California: pharmacies are not required to report prescription errors.

Family says pharmacy made a dangerous prescription mistake

https://www.10news.com/longform/team10-family-says-pharmacy-made-a-dangerous-prescription-mistake

An east county family is asking a pharmacy to change its protocols after they say the wrong dosage information on their child’s prescription almost put him in the hospital.

This latest case is another example of errors that state officials might not know about. 

“I am angry,” said Shannon Beasley.

Playing with his trucks or hitting home runs in his room is where you’re likely to find three-year-old Michael.

“Michael does not lay around,” she said. “If we can get him to sit for a 45-minute paw patrol episode that’s a good day.”

So when his mom noticed he was more lethargic, she knew something was wrong.

“He kept laying around saying, mom, I’m tired but couldn’t sleep,” she said.

‘Wait, mam. Read that one more time’

Beasley said a doctor diagnosed Michael with an ear infection.

The doctor prescribed Cefdinir, an antibiotic used to treat infections. They had the prescription electronically sent to a Walmart pharmacy in El Cajon.

“My husband gets there, signs in, gets his prescriptions, brings it home,” she said. “I gave him the first dose, later that evening I gave him the second dose because the bottle said two times a day.”

Beasley said three days into the routine Michael wasn’t getting any better. He was tired, refusing to eat, had diarrhea, and was not his normal, destroying-the-house self.

Beasley had enough and called the nurses’ line. She said the nurse asked her to read the prescription and dosage information from the bottle.

“She’s like, ‘Wait, mam. Read that one more time,’ and I read it to her again,” she said. “It was four ml’s (milliliters) twice a day, and she says, ‘No, mam. The doctor prescribed four ml’s once a day.'”

She says the instructions on doses per day were wrong.

“I was giving him more than what he, and I was the one making him sick,” Beasley said.

‘I feel like there is no room for error in this job’

She hung up the phone, contacted poison control and rushed Michael to a doctor.

Michael was severely dehydrated, but Beasley said stopping the medicine the day before was helpful. 

She called the Walmart pharmacy, then received a phone call from the company.

“Walmart’s claim department contacted me with an apology and what not, but unfortunately, I feel like there is no room for error in this job. And luckily I took him off of this sooner, but if not, who knows what the outcome would have been,” she said.

In a statement, a spokesperson for Walmart wrote:

“We work hard every day to ensure we live up to the high standards we set for ourselves and that our customers expect. We have quality control measures in place to help ensure that our customers receive the exact medications prescribed. In this individual case, we deeply regret this incident occurred despite our quality control measures. We have apologized to the Beasley family and continue to stand ready to work with them to resolve this matter. We take customer safety seriously and have reviewed our procedures carefully to avoid a similar incident in the future.”

Team 10 discovered the California State Board of Pharmacy issues hundreds of citations to pharmacists each year for dispensing errors.

But those errors are only what the state knows about. In California, pharmacies are not required to report those errors.

In April, the head of the agency told Team 10 the board relies on consumer complaints and court settlements to identify wrongdoings.

“We strongly believe that pharmacists do not deliberately make errors,” said Board of Pharmacy Executive Officer Virginia Herold. “If they do, that would be a formal disciplinary matter, and we would move very quickly to remove them from practice.”

The board received more than 3,000 complaints during the 2016-17 fiscal year

According to information obtained by Team 10, the board received more than 3,000 complaints during the 2016-17 fiscal year. 

During that time, it issued more than 2,000 citations for pharmacist and pharmacy wrongdoings and referred more than 350 cases to the California Office of the Attorney General.

Herold told Team 10 pharmacies are required to keep records of all dispensing errors. 

After a mistake, the pharmacy must initiate a quality assurance review looking at what happened and who is responsible. 

After what happened with her son’s medication, Beasley believes there’s no room for error in a pharmacy.

The easiest way to prevent a dispensing error is to take the time to talk to your pharmacist, according to experts. 

If you want to learn more about pharmacists and disciplinary actions or to report a dispensing error, you can do that on the California State Board of Pharmacy website. https://www.pharmacy.ca.gov/consumers/complaint_info.shtml

Time for TERM LIMITS for SENATOR CLAIRE MCCASKILL (D-MO)?

Prominent Pain Doctor Faces Hundreds of Lawsuits

Imagine spending your retirement defending yourself against hundreds of lawsuits in courthouses around the country – all of them alleging that you played a key role in starting the opioid crisis and that you were indirectly responsible for thousands of overdose deaths.

“It is mind boggling to me and its frightening, actually. I don’t know how I’m going to defend myself,” says Lynn Webster, MD, a pain management expert and former president of the American Academy of Pain Medicine. “Right now, we’re just trying to keep our head above the water.”

Webster has been named as a defendent in so many class action lawsuits – along with Purdue Pharma, Johnson & Johnson, Endo, Janssen and other opioid manufacturers – that he’s lost track. He knows of at least 80 lawsuits but believes there are many more.

“I think it could be several hundred,” he says.

The latest one was filed this week by Salt Lake County, Utah — where Webster lives — alleging that drug makers employed him in deceptive marketing practices that downplayed the risks of addiction and overdose. Like the other lawsuits by states, counties and cities, Salt Lake County seeks to recover taxpayer money spent on treating addiction, combating opioid abuse and policing opioid related crimes.    

 DR. LYNN WEBSTER

DR. LYNN WEBSTER

“Utah’s opioid crisis stems directly from a callously deceptive marketing scheme that was spearheaded by certain opioid manufacturers and perpetuated by prominent doctors they bankrolled,” the lawsuit alleges.

“Dr. Webster’s advocacy of opioids was designed to create a veneer of impartiality. But Dr. Webster was a forceful proponent of the concept of ‘pseudoaddiction,’ the notion that addictive behaviors should be seen not as a warning, but as indicators of undertreated pain. The only way to differentiate between the two, Dr. Webster claims, was to increase a patient’s dose of opioids.”

Until he retired from clinical practice in 2010, Webster operated the Lifetree Pain Clinic in Salt Lake City. The lawsuit makes a point of mentioning that at least 20 of Webster’s patients died from overdoses and that he was investigated – but never charged with a crime — by the DEA and the U.S. Senate Finance Committee.

“Most of what they have in there, at least about me, is false. And I think I can prove that,” Webster told PNN.

A footnote in the lawsuit contains the curious but important disclaimer that “Salt Lake County asserts no claim against Dr. Webster arising from his medical practice. The claims against Dr. Webster relate solely to his participation, as a KOL and otherwise, in Manufacturing Defendants deceptive marketing campaign.”

‘Key Opinion Leader’

KOL is an acronym for “key opinion leader” – a euphemism for doctors alleged to be so influential that they helped convince other physicians to prescribe more opioids. Webster and three other pain doctors — Russell Portenoy, Perry Fine and Scott Fishman — are portrayed in the lawsuits as KOLs who greedily accepted millions of dollars in payments from drug makers in return for their promotion of opioids.

“It’s mind boggling to think how four individuals can be accountable for essentially brainwashing all of the doctors in the country to do something intentionally to make pharmaceutical countries rich. How can anyone think that is plausible? It’s crazy,” says Webster. “Most of the pharmaceutical companies that they’ve listed I never received a dime from.”

According to the Salt Lake County lawsuit, Webster was “handsomely rewarded for his efforts,” receiving nearly $2 million from opioid manufacturers from 2009 to 2013. Webster says that dollar amount is unfair and misleading because most of it stems from his work as a researcher. He is currently Vice President of Scientific Affairs at PRA Health Sciences, a clinical research company.

“If you’re a principal investigator in a research program that has contracted with a pharmaceutical company, that money goes under your name. But its money to conduct a trial. Not a penny of it goes to me,” says Webster. “I have received compensation for consultant work and advisory boards. My consultant work is because of my area of expertise. That’s not unusual. And I do not speak for a company’s product. I do not benefit at all because I personally have no shares in any pharmaceutical company.”

Since retiring from clinical practice, Webster has become an outspoken critic of efforts by the government and insurance industry to limit opioid prescribing — which he believes have gone too far and unfairly punish pain patients, while ignoring the larger issue of illicit fentanyl, heroin and other black market drugs.

He’s written a book, called “The Painful Truth” and self-financed a PBS documentary by the same name.  Webster also comments frequently on PNN about opioid related issues.

With so many lawsuits hanging over him, Webster’s financial future is uncertain.  He says he and his fellow KOLs could be bankrupted by legal fees before any of the lawsuits come to trial.

.jpg

“We don’t have any big pocket that’s going to pay for anything,” he said. “If a jury decided to award money from us, they wouldn’t get any money, because there is no money. We would be all bankrupt by the time we got to court.”

Drug makers, on the other hand, do have big pockets. And during the 1990’s many of the same law firms now involved in opioid litigation helped win big settlements with the tobacco industry worth upwards of $200 billion.  That includes the law firm of Hagens Berman, which is handling the Salt Lake County lawsuit. The firm also represents the city of Seattle in a nearly identical lawsuit against opioid makers, in which Webster is named as a KOL.

Webster is also named in a string of lawsuits filed by the law firm of Simmons Hanly Conroy, which represents dozens of states, counties and cities. Simmons will pocket one-third of the proceeds from any opioid settlement,  which could run into hundreds of billions of dollars.

Simmons is well connected politically, having donated $219,000 to the re-election campaign of Missouri Sen. Claire McCaskill (D), who coincidentally released a report in February that’s highly critical of patient advocacy groups and medical associations for accepting money from opioid manufacturers.

It is against these political, financial and legal forces that Webster must find a way to defend himself.

“The body of the allegations are inaccurate, misleading and irresponsibly paint a picture which ignores the realities of Dr. Webster’s compassionate commitment to alleviating suffering in his chronic pain patients,” Peter Striba, Webster’s attorney, wrote in a letter to the Salt Lake Tribune. “It is estimated that there are approximately one-hundred million chronic pain patients in our Country, and it is very telling that their suffering and their medical condition is entirely absent in the narrative of the Complaint.” 

My Pharmacist Humiliated Me When He Refused to Fill My Hormone Prescription and ACLU cares about this denial

My Pharmacist Humiliated Me When He Refused to Fill My Hormone Prescription

https://www.aclu.org/blog/lgbt-rights/transgender-rights/my-pharmacist-humiliated-me-when-he-refused-fill-my-hormone

On a recent day in April, I left my doctor’s office elated. I was carrying my first prescriptions for hormone therapy. I was finally going to start seeing my body reflect my gender identity and the woman I’ve always known myself to be.

I went straight from my doctor to the CVS in my town, Fountain Hills, Arizona, which is a suburb of Phoenix. I handed over the three prescriptions that my doctor, who specializes in hormone therapy, had just given me. For more treatment information on hormone therapy, Read More Here

That’s when my day took a turn. After years of working to affirm my identity in a world where transgender people are questioned constantly about how well they know themselves, the pharmacist refused to fill one of the prescriptions needed to affirm my identity.

He did not give me a clear reason for the refusal. He just kept asking, loudly and in front of other CVS staff and customers, why I was given the prescriptions.

Embarrassed and distressed, I nearly started crying in the middle of the store. I didn’t want to answer why I had been prescribed this hormone therapy combination by my doctor. I felt like the pharmacist was trying to out me as transgender in front of strangers. I just froze and worked on holding back the tears.

When I asked for my doctor’s prescription note, the pharmacist refused to give it back, so I was not even able to take it to another pharmacy to have my prescription filled. I left the store feeling mortified. One can follow this link and for the best testosterone therapy click here.

When I got home, I called my doctor’s office to explain what happened. The office staff tried to intervene by calling the pharmacist, but he still refused to fill my prescription without explicitly explaining why. My doctor ended up having to call the prescription into the local Walgreens, where the medication was filled without question. I transferred all of my prescriptions there so that I never again have to see the pharmacist who discriminated against me.I have contacted CVS’ corporate complaint line multiple times, but no one has addressed my concerns or offered me an apology.

My family supports me, fortunately, and helped me work through the anger and humiliation this experience caused. But many other transgender people are not as fortunate as I am. I don’t want to think about what might happen if this pharmacist mistreats a transgender person who does not have a good social support system.

Today, I filed a complaint with the Arizona State Board of Pharmacy and am publicly asking CVS to take action and apologize for the way I was treated. CVS has received perfect marks for the past four years in the Human Rights Campaign’s Corporate Equality Index, which is a valuable tool for assessing corporate policies and practices pertinent to lesbian, gay, bisexual, transgender and queer employees. But something is still not right. Measures should be in place to ensure no other customer is humiliated like I was.

Through training and written policies, the company needs to make it clear to their employees — especially their pharmacists — that transgender customers deserve respect. No healthcare worker should rely on personal beliefs to reject decisions made by doctors and their transgender patients about medically necessary care.

It is interesting to see that the ACLU is interested in a pt being discriminated at the pharmacy dept.. unfortunately I can’t count the number of chronic pain pts that I have read about contacting ACLU and being told that they don’t have the resources  or maybe “the interest” in pursuing any action against the various pharmacies against that type of discrimination.

I wonder if any charges will be placed against the pharmacist because he basically STOLE/CONFISCATED the prescription from the pt…. because it is the property of the pt.

One has to ask.. where was this Pharmacist’s “moral compass” when he was going thru pharmacy school ? or did his “moral compass”changed directions once he got out into the real world ?